 |
Top 18 medical and healthcare startups in Ireland
Oct 12, 2024 | By Jason Kwon | 28 |
1
Funding: $20.1M
Luminate develops world's first portable, comfortable, and effective treatment for chemotherapy induced hair loss.
Luminate develops world's first portable, comfortable, and effective treatment for chemotherapy induced hair loss.
2
Funding: $393M
LetsGetChecked offers a health test kit service so that you can take various common laboratory tests from the comfort of your home
LetsGetChecked offers a health test kit service so that you can take various common laboratory tests from the comfort of your home
3
Funding: $219.2M
Juvenescence is a bio-pharma development company developing therapies focused on allowing people worldwide to live longer, healthier lives.
Juvenescence is a bio-pharma development company developing therapies focused on allowing people worldwide to live longer, healthier lives.
4
Funding: $155M
Transforming cancer treatments and the lives of cancer patients by targeting the molecular pathways that drive the most aggressive and resistant forms of cancer.
Transforming cancer treatments and the lives of cancer patients by targeting the molecular pathways that drive the most aggressive and resistant forms of cancer.
5
Funding: $153.9M
SynOx is developing emactuzumab, a best-in-class CSF1R targeted therapeutic antibody designed to target and deplete tumour-associated macrophages in the tumour tissue.
SynOx is developing emactuzumab, a best-in-class CSF1R targeted therapeutic antibody designed to target and deplete tumour-associated macrophages in the tumour tissue.
6
Funding: $106.5M
Nuritas combines artificial intelligence and genomics to discover and unlock natural bioactive peptides with extraordinary health benefits
Nuritas combines artificial intelligence and genomics to discover and unlock natural bioactive peptides with extraordinary health benefits
7
Funding: $82.1M
FIRE1 offers an implant that allows for remote monitoring of patients with heart failure.
FIRE1 offers an implant that allows for remote monitoring of patients with heart failure.
8
Funding: $63.8M
Inflazome develops targeted therapies for inflammatory diseases. Inflammasomes generate signals that cause immune cells to fight infections.
Inflazome develops targeted therapies for inflammatory diseases. Inflammasomes generate signals that cause immune cells to fight infections.
9
Funding: $54M
LUMA Vision develops a 4D imaging and navigation end-to-end platform for cardiac applications, focusing on point-of-therapy data delivery.
LUMA Vision develops a 4D imaging and navigation end-to-end platform for cardiac applications, focusing on point-of-therapy data delivery.
10
Funding: €49M
Priothera is dedicated to improving the lives of patients suffering from hematological malignancies by delivering an innovative immune modulator to enhance the curative potential of allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in these patients.
Priothera is dedicated to improving the lives of patients suffering from hematological malignancies by delivering an innovative immune modulator to enhance the curative potential of allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in these patients.
